| scholarly article | Q13442814 |
| P2093 | author name string | Mark A Geyer | |
| Adam L Halberstadt | |||
| Diana L Price | |||
| Mahálah R Buell | |||
| P2860 | cites work | The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study | Q24606265 |
| Initial characterization of PMMA as a discriminative stimulus | Q28239102 | ||
| Pharmacological studies of the acute and chronic effects of (+)-3, 4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/1D) receptors. | Q33871547 | ||
| Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors | Q34087847 | ||
| Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens | Q34559275 | ||
| Drug discrimination studies with MDMA and amphetamine | Q34560372 | ||
| (+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative stimulus in studies of 3,4-methylenedioxy-methamphetamine-like behavioral activity | Q35006123 | ||
| Acute Psychological and Neurophysiological Effects of MDMA in Humans | Q35105559 | ||
| Alpha1-adrenergic receptors mediate the locomotor response to systemic administration of (+/-)-3,4-methylenedioxymethamphetamine (MDMA) in rats | Q35990486 | ||
| The psychotherapeutic potential of MDMA (3,4-methylenedioxymethamphetamine): an evidence-based review | Q36734781 | ||
| Locomotor stimulation produced by 3,4-methylenedioxymethamphetamine (MDMA) is correlated with dialysate levels of serotonin and dopamine in rat brain | Q36800689 | ||
| Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats | Q36823553 | ||
| Further pharmacological characterization of 5-HT(2C) receptor agonist-induced inhibition of 5-HT neuronal activity in the dorsal raphe nucleus in vivo | Q37481197 | ||
| MDMA-assisted psychotherapy using low doses in a small sample of women with chronic posttraumatic stress disorder. | Q40028400 | ||
| Raphe unit activity in freely moving cats: Correlation with level of behavioral arousal | Q40215755 | ||
| Role of the serotonin 5-HT2A receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamine | Q40513141 | ||
| The effects of MDMA and other methylenedioxy-substituted phenylalkylamines on the structure of rat locomotor activity | Q41090540 | ||
| Tolerance and cross-tolerance to the activating effects of 3,4-methylenedioxymethamphetamine and a 5-hydroxytryptamine1B agonist | Q41987439 | ||
| Diurnal differences in rat's motor response to amphetamine | Q74587458 | ||
| The silent and selective 5-HT1A antagonist, WAY 100635, produces via an indirect mechanism, a 5-HT2A receptor-mediated behaviour in mice during the day but not at night. Short communication | Q77591895 | ||
| 3,4-methylenedioxymethamphetamine (MDMA)-induced release of endogenous serotonin from the rat dorsal raphe nucleus in vitro: Effects of fluoxetine and tryptophan | Q84306230 | ||
| Circadian variation in the activity of the 5-HT(1B) autoreceptor in the region of the suprachiasmatic nucleus, measured by microdialysis in the conscious freely-moving rat | Q42091625 | ||
| Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDA) analogs | Q42202438 | ||
| Stimulant and hallucinogenic behavioral profiles of 3,4-methylenedioxymethamphetamine and N-ethyl-3,4-methylenedioxyamphetamine in rats. | Q42202646 | ||
| Diurnal variations in natural and drug reward, mesolimbic tyrosine hydroxylase, and clock gene expression in the male rat. | Q43238374 | ||
| Differentiation of presumed serotonergic dorsal raphe neurons in relation to behavior and wake-sleep states | Q43678437 | ||
| Pharmacological studies of the acute effects of (+)-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-HT(1B/1D) and 5-HT(2) receptors | Q43829046 | ||
| Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram | Q43842041 | ||
| Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans | Q43842050 | ||
| Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents | Q43913092 | ||
| Multiple 5-HT receptors are involved in the effects of acute MDMA treatment: studies on locomotor activity and responding for conditioned reinforcement | Q44067276 | ||
| Blockade of serotonin 5-HT 1B and 5-HT 2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes | Q44423335 | ||
| Effects of dopamine D1- or D2-like receptor antagonists on the hypermotive and discriminative stimulus effects of (+)-MDMA. | Q44830693 | ||
| Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats. | Q45072510 | ||
| MDMA-like stimulus effects of alpha-ethyltryptamine and the alpha-ethyl homolog of DOM. | Q45085781 | ||
| Differential contributions of dopamine D1, D2, and D3 receptors to MDMA-induced effects on locomotor behavior patterns in mice. | Q45968734 | ||
| Amphetamine derivatives induce locomotor hyperactivity by acting as indirect serotonin agonists. | Q46016057 | ||
| 5HT-2 mediation of acute behavioral effects of hallucinogens in rats | Q46108266 | ||
| Dissociation of multiple effects of acute LSD on exploratory behavior in rats by ritanserin and propranolol | Q46119966 | ||
| Serotonin1B receptor activation mimics behavioral effects of presynaptic serotonin release | Q46176249 | ||
| Evidence for serotonin synthesis-dependent regulation of in vitro neuronal firing rates in the midbrain raphe complex | Q46520796 | ||
| Role of 5-HT2A and 5-HT2C/B receptors in the acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on striatal single-unit activity and locomotion in freely moving rats | Q46587077 | ||
| Behavioral characterization of alpha-ethyltryptamine, a tryptamine derivative with MDMA-like properties in rats | Q46590026 | ||
| Diurnal locomotor activity in rats: Effects of hippocampal ablation and adrenalectomy | Q48317196 | ||
| Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum | Q48440490 | ||
| Circadian and seasonal rhythms of 5-HT receptor subtypes, membrane anisotropy and 5-HT release in hippocampus and cortex of the rat | Q48464186 | ||
| Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on 5-HT cell firing and release: comparison between dorsal and median raphe 5-HT systems | Q48502115 | ||
| Methylphenidate: diurnal effects on locomotor and stereotypic behavior in the rat. | Q48552314 | ||
| Locomotor response to MDMA is attenuated in knockout mice lacking the 5-HT1B receptor | Q48705199 | ||
| Daily variations of serotonin metabolism in the rat brain | Q48735090 | ||
| Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naïve healthy volunteers | Q48788983 | ||
| Effects of MDMA ('ecstasy') on firing rates of serotonergic, dopaminergic, and noradrenergic neurons in the rat. | Q48899386 | ||
| Effects of certain hallucinogenic amphetamine analogues on the release of [3H]serotonin from rat brain synaptosomes | Q48948400 | ||
| 3,4-Methylenedioxymethamphetamine-induced release of serotonin and inhibition of dorsal raphe cell firing: potentiation by L-tryptophan | Q49050896 | ||
| Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions. | Q51584922 | ||
| The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') in healthy volunteers. | Q51971591 | ||
| Psychological effects of MDE in normal subjects. Are entactogens a new class of psychoactive agents? | Q52038043 | ||
| Structure-activity relationships of MDMA and related compounds: a new class of psychoactive drugs? | Q52243743 | ||
| Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic class. | Q52260167 | ||
| A proposed animal model for hallucinogens based on LSD's effects on patterns of exploration in rats. | Q52495495 | ||
| Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled study. | Q55032917 | ||
| MDMA (3,4-methylenedioxymethamphetamine) inhibits the firing of dorsal raphe neurons in brain slices via release of serotonin | Q69375247 | ||
| Circadian rhythm of serotonin receptor in rat brain | Q69619977 | ||
| Effects of DOM and DMT in a proposed animal model of hallucinogenic activity | Q69838660 | ||
| Multivariate assessment of locomotor behavior: pharmacological and behavioral analyses | Q69886468 | ||
| Release of serotonin induced by 3,4-methylenedioxymethamphetamine (MDMA) and other substituted amphetamines in cultured fetal raphe neurons: further evidence for calcium-independent mechanisms of release | Q70933300 | ||
| Circadian rhythm in the response of central 5-HT1A receptors to 8-OH-DPAT in rats | Q71350105 | ||
| Effects of monoamine oxidase inhibitors on release of dopamine and 5-hydroxytryptamine from rat striatum in vitro | Q71507774 | ||
| Circadian variation in the head twitch response produced by 5-methoxy-N1,N1-dimethyltryptamine and p-chloroamphetamine in the mouse | Q72642725 | ||
| Circadian rhythm in the hypothermic response to serotonin1A receptor agonist 8-OH-DPAT in rats | Q73377457 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 88-94 | |
| P577 | publication date | 2012-03-31 | |
| P1433 | published in | Pharmacology, Biochemistry and Behavior | Q15716554 |
| P1476 | title | Differences in the locomotor-activating effects of indirect serotonin agonists in habituated and non-habituated rats | |
| P478 | volume | 102 |
| Q36610017 | Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products | cites work | P2860 |
Search more.